Reference number : 236-2012-2013-Q2-00094, amendment number : , agreement type : G, recipient legal name : CHERKASOV, Artem, recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V6T 1Z1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 687735.0, agreement start date : 2012-10-01, agreement end date : 2018-03-31, description english : Next generation anti-androgens for the treatment of castration-resistant prostate cancers, description french : Next generation anti-androgens for the treatment of castration-resistant prostate cancers, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2017-18), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2017-18), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada